Cargando…
Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease
BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations....
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492935/ https://www.ncbi.nlm.nih.gov/pubmed/36160803 http://dx.doi.org/10.3389/fped.2022.939119 |
_version_ | 1784793584158900224 |
---|---|
author | Zhong, Taowei Song, Xinli Liu, Yiping Sun, Mengting Zhang, Senmao Chen, Letao Diao, Jingyi Li, Jinqi Li, Yihuan Shu, Jing Wei, Jianhui Zhu, Ping Wang, Tingting Qin, Jiabi |
author_facet | Zhong, Taowei Song, Xinli Liu, Yiping Sun, Mengting Zhang, Senmao Chen, Letao Diao, Jingyi Li, Jinqi Li, Yihuan Shu, Jing Wei, Jianhui Zhu, Ping Wang, Tingting Qin, Jiabi |
author_sort | Zhong, Taowei |
collection | PubMed |
description | BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations. METHODS: A case–control study involving 592 CHD cases, 617 health controls, and their mothers was performed. The exposures of interest were single nucleotide polymorphisms (SNPs) of the MTHFR gene, maternal folic acid use, and the time when folic acid use was started. We applied the logistic regression model to explore the strength of association. RESULTS: Our findings showed that mothers lacking folic acid intake had a significantly higher risk of CHD in offspring (aOR = 2.00; 95%CI: 1.34–2.98). Mothers who started to use folic acid from the first trimester of the fetation (aOR = 1.65; 95% CI: 1.22–2.23) or from the second trimester of the fetation (aOR = 7.77; 95% CI: 2.52–23.96), compared with those starting to use folic acid from 3 months previous to the conception, were at a significantly higher risk of CHD in offspring. Genetic variants at rs2066470 (AA vs. GG: aOR = 5.09, 95%CI: 1.99–13.03), rs1801133 (AA vs. GG: aOR = 2.49, 95%CI: 1.58–3.93), and rs1801131 (TG vs. TT: aOR = 1.84, 95%CI: 1.36–2.50; GG vs. TT: aOR = 3.58, 95%CI: 1.68–7.63) were significantly associated with the risk of CHD based on the multivariate analysis. Additionally, statistically significant interactions between maternal folic acid intake and genetic variants of the MTHFR gene at rs1801133 and rs1801131 were observed. CONCLUSION: An association of maternal folic acid intake and the time when intake was started with the risk of CHD in offspring was found. What's more, maternal folic acid fortification may help counteract partial of the risks of CHD in offspring attributable to MTHFR genetic mutations. REGISTRATION NUMBER: http://www.chictr.org.cn/edit.aspx?pid=28300&htm=4, identifier: ChiCTR1800016635. |
format | Online Article Text |
id | pubmed-9492935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94929352022-09-23 Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease Zhong, Taowei Song, Xinli Liu, Yiping Sun, Mengting Zhang, Senmao Chen, Letao Diao, Jingyi Li, Jinqi Li, Yihuan Shu, Jing Wei, Jianhui Zhu, Ping Wang, Tingting Qin, Jiabi Front Pediatr Pediatrics BACKGROUND: To systematically evaluate the association of MTHFR genetic polymorphisms, maternal folic acid intake, and the time when folic acid intake was started with the risk of congenital heart disease (CHD) and investigated the role of their interaction on infant CHD risk in Chinese populations. METHODS: A case–control study involving 592 CHD cases, 617 health controls, and their mothers was performed. The exposures of interest were single nucleotide polymorphisms (SNPs) of the MTHFR gene, maternal folic acid use, and the time when folic acid use was started. We applied the logistic regression model to explore the strength of association. RESULTS: Our findings showed that mothers lacking folic acid intake had a significantly higher risk of CHD in offspring (aOR = 2.00; 95%CI: 1.34–2.98). Mothers who started to use folic acid from the first trimester of the fetation (aOR = 1.65; 95% CI: 1.22–2.23) or from the second trimester of the fetation (aOR = 7.77; 95% CI: 2.52–23.96), compared with those starting to use folic acid from 3 months previous to the conception, were at a significantly higher risk of CHD in offspring. Genetic variants at rs2066470 (AA vs. GG: aOR = 5.09, 95%CI: 1.99–13.03), rs1801133 (AA vs. GG: aOR = 2.49, 95%CI: 1.58–3.93), and rs1801131 (TG vs. TT: aOR = 1.84, 95%CI: 1.36–2.50; GG vs. TT: aOR = 3.58, 95%CI: 1.68–7.63) were significantly associated with the risk of CHD based on the multivariate analysis. Additionally, statistically significant interactions between maternal folic acid intake and genetic variants of the MTHFR gene at rs1801133 and rs1801131 were observed. CONCLUSION: An association of maternal folic acid intake and the time when intake was started with the risk of CHD in offspring was found. What's more, maternal folic acid fortification may help counteract partial of the risks of CHD in offspring attributable to MTHFR genetic mutations. REGISTRATION NUMBER: http://www.chictr.org.cn/edit.aspx?pid=28300&htm=4, identifier: ChiCTR1800016635. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9492935/ /pubmed/36160803 http://dx.doi.org/10.3389/fped.2022.939119 Text en Copyright © 2022 Zhong, Song, Liu, Sun, Zhang, Chen, Diao, Li, Li, Shu, Wei, Zhu, Wang and Qin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Zhong, Taowei Song, Xinli Liu, Yiping Sun, Mengting Zhang, Senmao Chen, Letao Diao, Jingyi Li, Jinqi Li, Yihuan Shu, Jing Wei, Jianhui Zhu, Ping Wang, Tingting Qin, Jiabi Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title | Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title_full | Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title_fullStr | Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title_full_unstemmed | Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title_short | Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
title_sort | association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492935/ https://www.ncbi.nlm.nih.gov/pubmed/36160803 http://dx.doi.org/10.3389/fped.2022.939119 |
work_keys_str_mv | AT zhongtaowei associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT songxinli associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT liuyiping associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT sunmengting associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT zhangsenmao associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT chenletao associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT diaojingyi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT lijinqi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT liyihuan associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT shujing associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT weijianhui associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT zhuping associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT wangtingting associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease AT qinjiabi associationofmethylenetetrahydrofolatereductasegenepolymorphismsandmaternalfolicacidusewiththeriskofcongenitalheartdisease |